Phase 1 study of the PSMA-targeted tubulysin small-molecule drug conjugate EC1169 in patients with metastatic castrate-resistant prostate cancer (mCRPC): Study update Meeting Abstract


Authors: Morris, M. J.; Vogelzang, N. J.; Sartor, O.; Armour, A.; Petrylak, D.; Tolcher, A.; Ejadi, S.; Babiker, H. M.
Abstract Title: Phase 1 study of the PSMA-targeted tubulysin small-molecule drug conjugate EC1169 in patients with metastatic castrate-resistant prostate cancer (mCRPC): Study update
Meeting Title: 41st European Society for Medical Oncology Congress (ESMO)
Journal Title: Annals of Oncology
Volume: 27
Issue: Suppl. 6
Meeting Dates: 2016 Oct 7-11
Meeting Location: Copenhagen, Denmark
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2016-10-01
Start Page: vi249
Language: English
ACCESSION: WOS:000393912500728
DOI: 10.1093/annonc/mdw372.15
PROVIDER: wos
Notes: Meeting Abstract: 731P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    586 Morris